Journal: eLife
Article Title: Transcriptional control of motor pool formation and motor circuit connectivity by the LIM-HD protein Isl2
doi: 10.7554/eLife.84596
Figure Lengend Snippet: ( a ) Visualization of motor axons and neuromuscular junctions (NMJs) in P0 and P14 Gl muscles with Hb9::GFP (green) and α-bungarotoxin (BTX, red) immunoreactivity. Higher magnification views are provided for the boxed regions. The NMJ region is delineated by white lines in P0. Arrowheads indicate atrophic NMJs on overshooting axons in P14. ( b ) Number of NMJs in P0 Gl muscles (919±23 NMJs for control, vs. 772±44 for Isl2 knockout [KO], p=0.0257, n=4 muscles per group, three animals). ( c ) Secondary branch length (313±17 μm for control, vs. 92±8 μm for Isl2 KO, p<0.0001, n=90–120 axons per group, three animals) in P0 Gl muscles. ( d ) End plate area covered by motor axons (1.66±0.15 mm 2 for control, vs. 0.92±0.06 mm 2 for Isl2 KO, p=0.0014, n=4–5 muscles per group, three animals) in P0 Gl muscles. ( e ) End plate area covered by AChR clusters (1.04±0.05 mm 2 for control, vs. 0.61±0.05 mm 2 for Isl2 KO, p=0.0005, n=4–5 muscles per group, three animals) in P0 Gl muscles. ( f ) The number of AChR clusters (828±45 NMJs for Isl2 +/- , vs. 104±18 for Isl2 KO, p<0.0001, n=4 muscles per group, three animals) in P14 Gl muscles. ( g ) Axons extending beyond AChR clusters at P14 (0.26±0.07 axons for Isl2 +/- , vs. 3.92±0.29 for Isl2 KO, p<0.0001, n=39–46 100 μm intervals of end plate per group, three animals). ( h ) Visualization of motor axons and NMJs in P0, P14, and P28 tensor fasciae latae (Tfl) muscles. ( i ) The number of NMJs at P14 Tfl muscles (324±35 NMJs for Isl2 +/- vs. 34±5 for Isl2 KO, p=0.0002, n=4 muscles per group, three animals). ( j ) The number of axonal inputs in P28 Tfl muscles (1.09±0.09 axons for Isl2 +/- , vs. 4.08±0.40 axons for Isl2 KO, p<0.0001, n=11–13 NMJs per group, three animals). ( k ) Representative examples of NMJs with morphological defects at higher magnification in Gl muscles at P14. For compactness and fragmentation analysis, P28 NMJs were analyzed. A swelling axon is indicated by an arrowhead. (l–r) Percentage of faint NMJs (1.12 ± 0.48% for Isl2 +/- , vs. 70.47 ± 3.22% for Isl2 KO, p<0.0001, n=16–17 random fields per group), polyinnervated NMJs (0.81 ± 0.26% for Isl2 +/- , vs. 18.49 ± 2.75% for Isl2 KO, p<0.0001, n=8–17 random fields per group), number of axonal inputs (1.05±0.05 axons for Isl2 +/- , vs. 3.91±0.25 axons for Isl2 KO, p<0.0001, n=11–22 NMJs per group), area of AChR clusters (357±11 μm 2 for Isl2 +/- , vs. 701±57 μm 2 for Isl2 KO, p<0.0001, n=11–22 NMJs per group) and nerve terminal (270±10 μm 2 for Isl2 +/- , vs. 696±63 μm 2 for Isl2 KO, p<0.0001, n=11–22 NMJs per group), percentage of denervated NMJs (0.08 ± 0.08% for Isl2 +/- , vs. 4.95 ± 1.04% for Isl2 KO, p<0.0001, n=16–17 random fields per group), compactness (81.78 ± 1.07% for Isl2 +/- , vs. 55.52 ± 1.99% for Isl2 KO, p<0.0001, n=15–39 NMJs per group) and fragmentation (0.06±0.03 for Isl2 +/- , vs. 0.78±0.06 for Isl2 KO, p<0.0001, n=15–39 NMJs per group) of AChR clusters were measured. n=3 animals per group; box plots illustrate distribution with median (center line), first and third quartiles (box boundaries), and 10th and 90th percentiles (whisker); unpaired Student’s t-test in b - f , and o ; Mann-Whitney test in g , j , l - n and p - r ; see and source data for detailed n and statistics. ****p<0.0001, ***p<0.001, **p<0.01, *p<0.05, n.s.=not significant. Scale bars: ( a ) 200 μm (for low-magnification images) and 50 μm (for high-magnification images), ( h ) 20 μm in P0, 100 μm in P14, and 10 μm in P28. ( k ) 10 μm. Figure 8—source data 1. Quantification of gluteus (Gl) neuromuscular junctions (NMJs) in Isl2 +/- and Isl2 knockout (KO) mice for . Figure 8—source data 2. Quantification of tensor fasciae latae (Tfl) neuromuscular junctions (NMJs) in Isl2 +/- and Isl2 knockout (KO) mice for .
Article Snippet: The following antibodies were used: guinea pig anti-Olig2 , rabbit and guinea pig anti-HB9 , rabbit anti-GFP (Invitrogen), mouse anti-GFP (Sigma), rabbit anti-Isl1/2 , mouse anti-Isl2 (Santa Cruz), guinea pig anti-Lhx3 , goat anti-ChAT (Chemicon), rabbit anti-Foxp1 (Abcam), goat anti-Nkx6.1 (R&D Systems), goat anti-Isl1 (R&D Systems), guinea pig anti-Isl2 , rabbit anti-Lhx1 (Abcam), guinea pig anti-Scip , rabbit anti-Etv4 , rabbit anti-Tetramethylrhodamine (Invitrogen), guinea pig anti-vGluT1 (Millipore), rabbit anti-nNOS (Diasorin), and rabbit anti-pSMAD (Cell Signaling Technology).
Techniques: Muscles, Knock-Out, Whisker Assay, MANN-WHITNEY